The African Research Coalition for Health (ARCH) is an umbrella network of 11 African-led consortia largely funded by the DELTAS-Scheme of the African Academy of Science. It covers 54 African research institutions and universities across 17 Sub-Saharan countries. The coalition aims to build high-quality research capacity across the continent. Many ARCH partner institutions were among the first COVID-19 testing and diagnostics training nodes in their respective countries. Beyond testing, the institutions have also deployed their surveillance systems. And they’ve used their expertise in epidemiology, modelling and pathogen sequencing to help. A significant proportion of this expertise was developed under the ARCH framework. Many ARCH-trained researchers are currently launching immunology and pathogenesis studies to inform COVID-19 drug and vaccine development. By the end of 2021, ARCH will have supported training for more than 1000 high-quality PhD and postdoctoral researchers. The numbers will be similar for Master’s training and graduate research internships, across most spheres of health research.
SOURCE: THE CONVERSATION
More Stories
The Rise and Rise of Facebook in Africa
Horrific Blast Rocks Ghana’s Mining Town
Donors Called Out for Bringing Near to Expiration Vaccines
Africa’s Digital Economy Could Contribute $180bn to the Region’s Growth by Mid-decade
Las Vegas Resident’s Three-week Adventure through Egypt
Tunisia Needs “Deep Reforms” Such as Drastically Reducing its Vast Public Wage Bill
Credit Unions in Africa Switch to Fintech
Ghana’s Low Tax-to-GDP Ratio Makes it Hard to Finance its Developmental Agenda
Truck Delays at the Border Wreak Havoc for Uganda’s Fuel Users
Airlines Operating on the Continent Face Particular Challenges
The Inclusion of Rwanda as a Potential Relocation Destination for Migrants Raises Eyebrows
Sudanese Demand Return to Civilian Rule in Deadly Riots